Bridgewater Associates LP Sells 8,088 Shares of LifePoint Health Inc (LPNT)
Bridgewater Associates LP cut its stake in shares of LifePoint Health Inc (NASDAQ:LPNT) by 42.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,164 shares of the company’s stock after selling 8,088 shares during the period. Bridgewater Associates LP’s holdings in LifePoint Health were worth $545,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Point72 Asia Hong Kong Ltd lifted its position in shares of LifePoint Health by 1,897.5% in the first quarter. Point72 Asia Hong Kong Ltd now owns 2,417 shares of the company’s stock valued at $114,000 after buying an additional 2,296 shares during the last quarter. Bank of Montreal Can acquired a new stake in shares of LifePoint Health in the second quarter valued at approximately $169,000. Campbell & CO Investment Adviser LLC acquired a new stake in shares of LifePoint Health in the second quarter valued at approximately $211,000. Verition Fund Management LLC acquired a new stake in shares of LifePoint Health in the first quarter valued at approximately $224,000. Finally, People s United Financial Inc. acquired a new stake in shares of LifePoint Health in the second quarter valued at approximately $242,000.
Shares of NASDAQ LPNT opened at $64.35 on Tuesday. The company has a market cap of $2.50 billion, a PE ratio of 15.87, a PEG ratio of 1.62 and a beta of 0.65. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.63 and a current ratio of 1.85. LifePoint Health Inc has a 1-year low of $41.45 and a 1-year high of $65.35.
A number of analysts have recently issued reports on the company. BidaskClub raised LifePoint Health from a “sell” rating to a “hold” rating in a research report on Friday. William Blair reaffirmed a “hold” rating on shares of LifePoint Health in a research report on Friday, August 17th. Zacks Investment Research lowered LifePoint Health from a “hold” rating to a “sell” rating in a research note on Tuesday, July 24th. Credit Suisse Group increased their target price on LifePoint Health from $58.00 to $65.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 24th. Finally, BMO Capital Markets increased their target price on LifePoint Health from $62.00 to $65.00 and gave the stock a “market perform” rating in a research note on Tuesday, July 24th. Two equities research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $58.73.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
See Also: Penny Stocks, What You Need To Know
Want to see what other hedge funds are holding LPNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifePoint Health Inc (NASDAQ:LPNT).
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.